USPTO serial 79248414
ONT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 16, 2020
- Examiner
- O'BRIEN, ELIZABETH A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ONT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $1,275
Owner
OXFORD NANOPORE TECHNOLOGIES LIMITED
Oxford Science Park, GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
Oxford Science Park, GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
OXFORD NANOPORE TECHNOLOGIES LIMITED
Oxford Science Park, GB
Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical diagnostic reagents for scientific use; reagents for use in automated test systems; reagents for analytical tests; reagents for industrial use, namely, for food testing; reagents for use in science; reagents for laboratory use; reagents for use in molecular biology, biotechnology, microbiology, and bacteriology; reagents for nucleic acid amplification; reagents for use in forensic analysis; reagents for blood grouping; reagents for use in environmental testing and environmental analysis; reagents for testing water and other liquids; reagents for testing aqueous solutions; deoxyribonucleic acid, single stranded and double stranded deoxyribonucleic acid for laboratory and research use; ribonucleic acid for research purposes; peptide nucleic acids for laboratory purposes in the field of biochemical and scientific research; locked nucleic acids for use in analytical tests for scientific and research purposes; nucleic acids for scientific, forensic and research purposes; oligonucleotides for scientific and research purpose; oligosaccharides for scientific and research purposes; proteins for use in manufacture; biomedical compounds, namely, peptide substrates for use in analytical tests for scientific and research purposes; chemicals, enzymes and reagents for use in genome, DNA, RNA and nucleic acid synthesis; restriction endonucleases, polymerases, ligases, and glycosylases for scientific and research purposes; nucleotides, pyrimidines, and purines for scientific and research purposes; amino acids for laboratory or research use; saccharides for scientific and research purposes; reagents for biological processing; reagents for use in nucleic acid characterisation and nucleic acid sequencing; reagents for protein identification and analysis; chemicals for use in tests to detect diseases in plant life; reagents for formation of amphipathic membranes; chemicals, namely, buffer solutions used in analytical chemistry; aqueous solvents for industrial and commercial use; non-aqueous solvents for industrial and commercial use; isopropanol; ethanol not used as fuel; phenol; surfactants for use in the manufacture of synthetic detergents; silicone oils; silicone fluids; enzymes for scientific and research purposes; lytic enzymes including lysozyme, lyticase and cellulose for scientific and research purposes; proteases for scientific and research purposes; nucleases, including RNase, DNase and restriction enzymes for scientific and research purposes; chaotropes, including guanidine-HCl and guanidinium thiocyanate for scientific and research purposes; detergents for industrial and scientific use; proteins for use in analytical tests; all the aforesaid other than for medical or veterinary purposes; magnetic and non-magnetic microspheres made from synthetic materials including rubber, plastics or silicone, namely, beads for use in medical and scientific research | ACTIVE | — |
| 009 | Computer software for performing and controlling the analysis of data obtained from scientific tests and experiments; software for running an e-commerce platform; downloadable software for use in analysing, transmitting and receiving data via a global communications network; downloadable software for developing, running and communicating with software on data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; computer operating software; computer operating system software; operating software for data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices; sensors for detecting, manipulating and analysing biological, bacteriological, chemical and biochemical matter and DNA, RNA, proteins, polynucleic acids and small molecules; microarrays, and silicon chip based arrays for scientific or research purposes; micro-array chips; scientific apparatus, namely, electronic sensing apparatus for sensing and manipulating biological, bacteriological, chemical and biochemical matter and DNA, RNA, proteins, polynucleic acids and small molecules; scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, supervision, life-saving and teaching apparatus and instruments, namely, apparatus for testing gas, liquids and solids; apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, optical or electrochemical analysis and measurement of ions, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; portable apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, optical or electrochemical analysis and measurement of ions, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICS (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis; apparatus for the analysis of polynucleic acid sequences, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for the analysis of nucleic and polynucleic acids, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for the analysis of proteins, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for analysis of genetic information, genomic information and proteomic information, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICS (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis; apparatus and instruments for synthesizing chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for use in laboratory analysis; diagnostic and testing apparatus, for testing air quality, food, soil or water, not for medical purposes; electric and electronic monitoring apparatus and instruments, namely, electric monitors and monitor modules for monitoring electric current and electrical signals; computer programs, computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; scientific apparatus and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; data processing apparatus, devices and instruments; apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides for scientific research and scientific testing purposes; portable apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable computer hardware and data processing apparatus, all for the analysis and recordal of scientific data; computer peripheral devices; instruments and apparatus in the nature of electronic display interfaces for the display of information obtained from scientific equipment; silicon chips; DNA chips; analyte detector chips for scientific research and scientific testing use; biosensor chips for scientific research and scientific testing use; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples for use in scientific tests and experiments; batteries; rechargeable batteries; chargers for batteries; power packs, namely, battery packs; computer docking stations; apparatus for connecting and charging portable digital electronic devices; testing apparatus incorporating chemical or biological reagents for testing air quality; reaction units containing chemical or biological reagents, namely, reaction systems for scientific or research purposes; nanopore sensing devices for scientific research and scientific testing use | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for use in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the fields of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services; services relating to the synthesis of chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; scientific research for medical or veterinary purposes; DNA and RNA and polynucleic acid sequencing services for scientific research purposes; protein sequencing services for scientific research purposes; design and development of scientific instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; DNA and polynucleic acid testing services, namely, the analysis of DNA and polynucleic acids for scientific and scientific research purposes; scientific and technological services, namely, genome sequencing services for scientific testing and scientific research purposes; analysis and evaluation of data, not for medical treatment or diagnostic purposes, namely, scientific and medical data; computerised analysis of technical data namely, the results of scientific tests and experiments; remotely overseeing, monitoring and managing scientific and medical experiments and tests for scientific research purposes; remotely overseeing, monitoring and managing the analysis and evaluation of scientific and medical data for scientific research purposes; design of scientific experiments; analysis of data generated by scientific and medical experiments and tests for scientific research purposes; scientific and technological services, namely, biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific research purposes; scientific and technological services, namely, DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific research purposes; scientific and technological services, namely, genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of scientific information in the form of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests none being for medical treatment or diagnostic purposes; scientific and medical research and development services in the fields of scientific, technological and medical research; technical data analysis and evaluation services in the fields of scientific, medical technology and medical research; electronic data storage services; application service provider (ASP) services featuring computer software applications for data processing apparatus, scientific apparatus, medical and veterinary apparatus, computers, mobile phones, tablet computers and handheld mobile digital electronic devices for the analysis of scientific data; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks owned by OXFORD NANOPORE TECHNOLOGIES LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named ONT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 28, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 3, 2020 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Oct 3, 2020 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 16, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 16, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 12, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 27, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 27, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 31, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 31, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 27, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 11, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 11, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 11, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 24, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 21, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 21, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 21, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2020 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 22, 2020 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 22, 2020 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jan 22, 2020 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 25, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 20, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 7, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 6, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 6, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2019 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Aug 6, 2019 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Aug 6, 2019 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Aug 6, 2019 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Jul 31, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 24, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 19, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 16, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 26, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 26, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 13, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 12, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 9, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 5, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 27, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |